Pharma · Private company
Viatris Innovation GmbH
Track this companyFree. Adds Viatris Innovation GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials135 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline18
- CenerimodPhase 3 · Nephritis, LupusClinicalTrials.gov · fetched Nov 12, 2026
- CenerimodPhase 3 · Lupus Erythematosus, SystemicClinicalTrials.gov · fetched Nov 12, 2026
- SelatogrelPhase 3 · Acute Myocardial InfarctionClinicalTrials.gov · fetched Nov 12, 2026
- CenerimodPhase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- Cenerimod 0.5 mgPhase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- Cenerimod 1 mgPhase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- Cenerimod 2 mgPhase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- cenerimod 2 mg (ex-4 mg)Phase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- Cenerimod 4 mgPhase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- SelatogrelPhase 2 · Stable Coronary Artery DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- AC-076 for s.c. administrationPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- ACT-246475Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- CenerimodPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- ClopidogrelPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- PrasugrelPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- SelatogrelPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- SelatogrelPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- TicagrelorPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular TreatmentPHASE3 · RECRUITING · started Feb 9, 2026ClinicalTrials.gov NCT07201129 · fetched Nov 12, 2026
- A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy ParticipantsPHASE1 · COMPLETED · started Oct 7, 2025ClinicalTrials.gov NCT07133191 · fetched Nov 12, 2026
- Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus ErythematosusPHASE3 · ENROLLING_BY_INVITATION · started Jul 30, 2024ClinicalTrials.gov NCT06475742 · fetched Nov 12, 2026
- A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus ErythematosusPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 26, 2023ClinicalTrials.gov NCT05672576 · fetched Nov 12, 2026
- A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus ErythematosusPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 13, 2022ClinicalTrials.gov NCT05648500 · fetched Nov 12, 2026
- Selatogrel Outcome Study in Suspected Acute Myocardial InfarctionPHASE3 · ENROLLING_BY_INVITATION · started Aug 14, 2021ClinicalTrials.gov NCT04957719 · fetched Nov 12, 2026
- A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy SubjectsPHASE1 · COMPLETED · started Nov 6, 2020ClinicalTrials.gov NCT04557280 · fetched Nov 12, 2026
- Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian SubjectsPHASE1 · COMPLETED · started Aug 7, 2019ClinicalTrials.gov NCT04052360 · fetched Nov 12, 2026
- Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusPHASE2 · COMPLETED · started Dec 21, 2018ClinicalTrials.gov NCT03742037 · fetched Nov 12, 2026
- A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery DiseasePHASE2 · COMPLETED · started Jan 24, 2018ClinicalTrials.gov NCT03384966 · fetched Nov 12, 2026
- A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy SubjectsPHASE1 · COMPLETED · started Jan 24, 2018ClinicalTrials.gov NCT03430661 · fetched Nov 12, 2026
- A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the BodyPHASE1 · COMPLETED · started Nov 29, 2016ClinicalTrials.gov NCT03173625 · fetched Nov 12, 2026
- Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus ErythematosusPHASE1_PHASE2 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02472795 · fetched Nov 12, 2026